According to these results, the search for a relationship between the overexpression of APP, S100B, and IL-1β resulted in experiments showing that the activation of glia and the resultant increase of IL-1β and S100B in the nervous system influences the neuropathogenesis of both AD and DS. Here, S100B is linked to Alzheimer disease.